BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioAdaptives's price to sales ratio was 2.4× on Oct 19, 2026, against 158.7× a year earlier. Over the last 2 years it ranged from 1.5× to 492.0×, with a median of 22.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.4× | −28.4 |
| 2025 | Dec 31, 2025 | 30.8× | +12.0 |
| 2024 | Apr 30, 2024 | 18.8× | −339.0 |
| 2023 | Jan 31, 2023 | 357.8× | +89.4 |
| 2022 | Dec 30, 2022 | 268.4× | – |
See a number that looks wrong?